Non-hormonal management of menopause symptoms-the statement of the European Society of Gynecology.
Castelo-Branco Camil C, Kiesel Ludwig L, Yoldemir Tevfik T, Chabbert-Buffet Nathalie N et al.
Menopausal symptoms, particularly vasomotor symptoms (VMS), sleep disturbances, mood disorders, and genitourinary syndrome of menopause (GSM), affect a substantial proportion of women and may significantly impair the quality of life. Although menopausal hormone therapy (MHT) remains the most effective treatment, many women have contraindications to hormonal treatment or prefer non-hormonal options. To review and provide evidence-based recommendations on current non-hormonal interventions for the management of menopausal symptoms. The European Society of Gynecology convened an expert panel that performed a comprehensive literature review using MEDLINE and EMBASE. Clinical guidelines, systematic reviews, meta-analyzes, randomized controlled trials, and relevant primary studies evaluating non-hormonal interventions for menopausal symptoms were identified, critically appraised, and synthesized through a structured consensus process. Lifestyle modification, including healthy diet, regular physical activity, weight control, sleep hygiene, and behavioral interventions, forms the foundation of menopausal care. Among pharmacological therapies, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, gabapentin, clonidine, oxybutynin, and pregabalin demonstrate varying degrees of efficacy for VMS. Neurokinin receptor antagonists, particularly fezolinetant and elinzanetant, represent the most effective evidence-based non-hormonal pharmacologic therapies currently available. Cognitive behavioral therapy and clinical hypnosis effectively reduce VMS-related distress and improve sleep and quality of life. Evidence for complementary approaches such as mindfulness, yoga, acupuncture, acupressure, reflexology, phytoestrogens, S-equol, DT56a, purified pollen extracts, and black cohosh ranges from moderate to limited. For GSM, lubricants, moisturizers, hyaluronic acid preparations, and pelvic floor muscle training provide symptomatic benefit, whereas current evidence does not support routine use of vaginal laser therapy. Non-hormonal therapies provide effective and individualized treatment options for menopausal symptoms, particularly for women who are unable or unwilling to use MHT. Neurokinin receptor antagonists, selected pharmacologic agents, psychological interventions, and targeted GSM therapies represent the strongest evidence-based approaches currently available. The choice of treatment should consider symptom profile, contraindications, adverse effects, regulatory approval, and patient preferences.